Tech Company Financing Transactions
Infinity Bio Funding Round
Infinity Bio, based in Baltimore, raised $8 million in funding from Illumina Ventures, Propel Baltimore Fund and PTX Capital.
Transaction Overview
Company Name
Announced On
6/19/2025
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand its commercial footprint, accelerate development of its proprietary MIPSA platform, and launch new immune profiling services.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Baltimore, MD Undisclosed
USA
Baltimore, MD Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Inflammation and immunity are central to nearly all states of health and disease. Antibody reactivities carry detailed information about past and ongoing immune responses. Infinity Bio translates the antibody "reactome" -- the set of all possible binding interactions between antibodies and antigens -- into the biological inSIGHTs needed to transform your immunology research.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joy Nassif
Browse more venture capital transactions:
Prev: 6/19/2025: PreciseDx venture capital transaction
Next: 6/19/2025: Carefull venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs